AGIO - Agios Pharmaceuticals Stock Trading

Agios Pharmaceuticals Inc.(NASDAQ: AGIO) stock trading, description, contact, officers and directors.

About Agios Pharmaceuticals Inc.

Not available

Stock Information

Agios Pharmaceuticals Inc. Company Name:

AGIO Stock Symbol:

NASDAQ Market:

Get AGIO Alerts

News, Short Squeeze, Breakout and More Instantly...

AGIO - Agios Presents Updated Data from the Phase 1 Dose-escalation Study of Vorasidenib in Patients with IDH-mutant Non-enhancing Glioma

– Vorasidenib Demonstrated Prolonged Disease Control and Encouraging Preliminary Activity with Median Progression-free Survival of 31.4 Months – – Vorasidenib Demonstrated a Favorable Safety Profile at Doses Below 100mg Consistent with Previously Reported Data &#x...
AGIO - FDA Mishaps Have Investors Asking "What's Going On With bluebird bio?"

Gene-focused biotech bluebird bio (NASDAQ: BLUE) continues to experience prolonged difficulties in moving its flagship LentiGlobin immunotherapy for beta-thalassemia (a blood disorder that leads to lack of oxygen) to market in the U.S., leading many to question the company's fluency in regul...
AGIO - Agios Announces Publication of TIBSOVO® Phase 3 Data in The Lancet Oncology Demonstrating Significant Improvement in Progression-Free Survival Compared to Placebo in Previously Treated IDH1-Mutant Cholangiocarcinoma Patients

– TIBSOVO ® Is the First and Only IDH1 Inhibitor to Be Evaluated in a Phase 3 Clinical Trial for IDH1-Mutant Cholangiocarcinoma – CAMBRIDGE, Mass., May 19, 2020 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field of cellular metabol...